ArticleSurgery in practice and science2023
Management of small bowel obstruction and therapeutic role of contrast media: A multicenter study.
Article in Surgery in practice and science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Prospective Randomised Pilot Study on the Timing of Contrast Media Administration in Adhesive and Virgin Abdomen Small Bowel Obstruction.Medicina (Kaunas, Lithuania) · 2026Trial
- Outcomes of small bowel obstruction management in previously unoperated patients with a mid-term follow-up: a retrospective cohort study.BMC surgery · 2026Article
- Water-soluble contrast agent use in adhesional small bowel obstruction: a survey of surgical practices and clinical trial considerations.Annals of the Royal College of Surgeons of England · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adhesive small bowel obstruction (SBO) accounts for 55-75% of mechanical small bowel obstructions [1,2]. According to guidelines, water-soluble contrast media (CM) is suggested in the diagnostic work-up of adhesive SBO [3], [4], [5]. However, there is currently no consensus on the therapeutic role of water-soluble CM in adhesive SBO [6] or a generally approved protocol as to when CM should be administered, how often should radiographs be taken and how long conservative management can safely be pursued. Material and methods: The data of patients who were hospitalized for SBO in two regional hospitals of Estonia between January 2015 and December 2019 were retrospectively collected from the hospitals' electronic databases. Results: Of 1,008 patients with mechanical SBO included in analysis, 140 (13.9%) were operated on immediately. In the case of conservative management, 575 (66.2%) patients received CM. Resolution occurred in 75.8% of the patients who received CM and in 68.9% of the patients who did not ( Conclusion: The significantly higher rate of SBO resolution in the CM group suggests that CM may have a therapeutic role in SBO treatment, especially when it is administered within 12 h of admission. Patients with longer duration of symptoms and a history of one previous abdominal surgery need more likely surgical treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.